Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Imfinzi“
Suchtreffer
Begriffe & Kennungen
Imfinzi · 4.8 · Description of selected adverse reactions IMFINZI is associated with immune-mediated adverse reactions. Most o
Eintrag öffnenImfinzi · 4.8 · Elderly No overall differences in safety were reported between elderly (≥ 65 years) and younger patients.
Eintrag öffnenImfinzi · 4.8 · IMFINZI in combination with chemotherapy
Eintrag öffnenImfinzi · 4.8 · IMFINZI in combination with platinum-based chemotherapy followed by IMFINZI in combination with olaparib 300 m
Eintrag öffnenImfinzi · 4.8 · IMFINZI in combination with tremelimumab 300 mg The safety of IMFINZI given in combination with a single dose
Eintrag öffnenImfinzi · 4.8 · IMFINZI in combination with tremelimumab 75 mg and platinum-based chemotherapy The safety of IMFINZI given in
Eintrag öffnenImfinzi · 4.8 · IMFINZI was delayed or interrupted due to adverse reactions in 11.6% of patients. The most common adverse reac
Eintrag öffnenImfinzi · 4.8 · IMFINZI was delayed or interrupted due to adverse reactions in 13.1% of patients. The most common adverse reac
Eintrag öffnenImfinzi · 4.8 · IMFINZI was delayed or interrupted due to adverse reactions in 32.4% of patients. The most common adverse reac
Eintrag öffnenImfinzi · 4.8 · IMFINZI was discontinued due to adverse reactions in 3.7% of patients. The most common adverse reactions leadi
Eintrag öffnenImfinzi · 4.8 · IMFINZI was discontinued due to adverse reactions in 3.9% of patients. The most common adverse reactions leadi
Eintrag öffnenImfinzi · 4.8 · IMFINZI was discontinued due to adverse reactions in 6.2% of patients. The most common adverse reactions leadi
Eintrag öffnenImfinzi · 4.8 · IMFINZI was discontinued due to adverse reactions in 8.5% of patients. The most common adverse reactions leadi
Eintrag öffnenImfinzi · 4.8 · IMFINZI was discontinued in 4.6% of patients. The most common adverse reaction leading to treatment discontinu
Eintrag öffnenImfinzi · 4.8 · IMFINZI was interrupted due to adverse reactions in 49.4% of patients. The most common adverse reactions leadi
Eintrag öffnenImfinzi · 4.8 · IMFINZI was interrupted in 38.2% of patients. The most common adverse reactions leading to dose interruption w
Eintrag öffnenImfinzi · 4.8 · Immune mediated hypophysitis/hypopituitarism In the combined safety database with IMFINZI monotherapy, immune-
Eintrag öffnenImfinzi · 4.8 · Immune-mediated adrenal insufficiency In the combined safety database with IMFINZI monotherapy, immune-mediate
Eintrag öffnenImfinzi · 4.8 · Immune-mediated colitis In the combined safety database with IMFINZI monotherapy, immune-mediated colitis or d
Eintrag öffnenImfinzi · 4.8 · Immune-mediated endocrinopathies Immune-mediated hypothyroidism In the combined safety database with IMFINZI m
Eintrag öffnen